| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 115 |
| 1 | OLANZAPINE | 9 |
| 2 | ARIPIPRAZOLE | 8 |
| 3 | ARIPIPRAZOLE ORAL | 7 |
| 4 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 7 |
| 5 | LORAZEPAM | 6 |
| 6 | LITHIUM | 5 |
| 7 | LITHIUM BROMATUM | 5 |
| 8 | BISOPROLOL FUMARATE | 4 |
| 9 | RISPERIDONE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CABOTEGRAVIR SODIUM | 2 | 0.0012 |
| 1 | CLOZAPINE | 115 | 0.0009 |
| 2 | AMISULPRIDE | 2 | 0.0003 |
| 3 | RILPIVIRINE | 2 | 0.0003 |
| 4 | SCOPOLAMINE | 1 | 0.0003 |
| 5 | BENZTROPINE | 2 | 0.0003 |
| 6 | LOXAPINE | 1 | 0.0003 |
| 7 | SALINE NASAL SPRAY | 1 | 0.0002 |
| 8 | LITHIUM | 5 | 0.0002 |
| 9 | PRAZOSIN | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 118 | 0.0003 |
| 1 | Dopamine-2 Receptor Antagonist [EPC] | 2 | 0.0003 |
| 2 | Anticholinergic [EPC] | 1 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 4 | Central alpha-2 Adrenergic Agonist [EPC] | 1 | 0.0000 |
| 5 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 1 | 0.0000 |
| 6 | Cholinergic Nicotinic Agonist [EPC] | 1 | 0.0000 |
| 7 | Mood Stabilizer [EPC] | 3 | 0.0000 |
| 8 | Histamine-1 Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Benzodiazepine [EPC] | 7 | 0.0000 |